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Abstract
Rational Exposing animal models of mental illness to
addictive drugs provides an approach to understanding the
neural etiology of dual diagnosis disorders. Previous studies
have shown that neonatal ventral hippocampal lesions
(NVHL) in rats produce features of both schizophrenia
and addiction vulnerability.
Objective This study investigated ventral and dorsal striatal
dopamine (DA) efflux in NVHL rats combined with
behavioral sensitization to cocaine.
Methods Adult NVHL vs. SHAM-operated rats underwent
a 5-day injection series of cocaine (15 mg/kg/day) vs.
saline. One week later, rats were cannulated in nucleus
accumbens SHELL, CORE, or caudate–putamen. Another
week later, in vivo microdialysis sampled DA during
locomotor testing in which a single cocaine injection
(15 mg/kg) was delivered.
Results NVHLs and cocaine history significantly increased
behavioral activation approximately 2-fold over SHAM-
saline history rats. DA efflux curves corresponded time
dependently with the cocaine injection and locomotor curves
and varied significantly by striatal region: Baseline DA
levels increased 5-fold while cocaine-stimulated DA efflux
decreased by half across a ventral to dorsal striatal gradient.
However, NVHLs, prior cocaine history, and individual
differences in behavior were not underpinned by differential
DA efflux overall or within any striatal region.
Conclusion Differences in ventral/dorsal striatal DA efflux
are not present in and are not required for producing
differential levels of acute cocaine-induced behavioral
activation in NVHLs with and without a behaviorally
sensitizing cocaine history. These findings suggest other
neurotransmitter systems, and alterations in striatal network
function post-synaptic to DA transmission are more
important to understanding the interactive effects of
addictive drugs and mental illness.
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Introduction
Co-morbidity of addictions with schizophrenia and other
mental illnesses increases medical and psychiatric disability,
homelessness, criminal incarceration, and premature death in
these populations (Drake and Wallach 2000; O’Brien et al.
2004). Emerging findings suggest that the high prevalence of
substance disorders in psychiatric illnesses reflects an
involuntary neurobiological vulnerability to drug addiction
imparted by the same neuropathological substrates that
generate psychiatric symptoms (Chambers et al. 2001). This
integrated circuit theory of dual diagnosis has appeal
especially in the case of schizophrenia, given a wealth of
data implicating sub-cortical dopamine (DA) transmission in
this disorder and addictions.
Preclinical studies that combine neonatal ventral hippo-
campal lesions (NVHLs) in rats—an extensively character-
ized neurodevelopmental model of schizophrenia—and
drug addiction models support a unified neural basis for
psychiatric illness and addiction vulnerability. NVHLs
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produce a spectrum of developmental, clinical, and neuro-
biological features of human schizophrenia (Tseng et al.
2009). In this model, positive-like symptoms (e.g., behav-
ioral hyper-reactivity to novelty, stress, and psychostimu-
lants) emerge after adolescence and are reducible with
neuroleptics; cognitive deficits and negative symptom traits
are detectable earlier and are not treatment responsive.
Sensory gating, cortical electrophysiological patterns, and
various markers of prefrontal cortical/neuronal function and
anatomy, involving glutamatergic and GABAergic trans-
mission, are abnormal (Flores et al. 2005; Tseng et al. 2008,
2007; Vohs et al. 2010). Upon exposure to reinforcing
drugs, NVHLs show augmented addiction-related pheno-
types: Impulsivity in conditioned approach to natural
rewards is worsened by cocaine history; long-term behav-
ioral sensitization to cocaine, alcohol, and nicotine are all
accentuated (Berg and Chambers 2008; Chambers et al.
2005; Chambers and Taylor 2004; Conroy et al. 2007);
drug-seeking in cocaine and methamphetamine self-
administration are both enhanced (Chambers and Self
2002; Brady et al. 2008). The ventral hippocampus,
developmentally altered in NVHLs and functionally and
structurally altered in schizophrenia, sends direct glutama-
tergic projections to the nucleus accumbens (NAC) and
prefrontal cortical areas that project to the NAC (O’Donnell
and Grace 1995). As a primary receptive field of meso-
limbic DA projections, where addictive drugs potentiate
DA concentrations, the NAC is involved in the selection
and adaptability of motivated behavior (Kalivas and
Volkow 2005). Thus, understanding separate and combined
effects of NVHLs and addictive drug history on ventral
striatal DA circuits may provide important clues about the
genesis of dual diagnosis.
Previous work demonstrates that a behaviorally sensitiz-
ing cocaine history and NVHLs produce differential
patterns of prefrontal cortical/striatal network activation.
When combined in the same animals, these conditions
show compounding effects on dorsal striatal neural activa-
tion that directly correlates with degree of long-term
behavioral sensitization (Chambers et al. 2010). The present
study replicates this experimental design, while assessing
DA efflux into ventral striatal (NAC) and dorsal striatal
(caudate–putamen, CAPU) regions. Advancing from prior
studies that examined NAC DA efflux in living NVHL rats
(Brake et al. 1999; Corda et al. 2006; Lillrank et al. 1999;
Wan et al. 1996), the present study utilized a substantially
larger number of rats in a microdialysis–HPLC quantifica-
tion of DA efflux while examining (a) the separate and
combined impacts of NVHLs and a behaviorally sensitizing
cocaine history, (b) DA efflux across three ventral–dorsal
striatal compartments, and (c) DA concentration changes




Sprague–Dawley dams arriving at 14–17 days gestation and
housed under standard conditions produced litters of eight
to 14 pups on post-natal day (PD)0. On PD 7, males
weighing 16–19 g were randomized for surgeries with
balancing of NVHL/SHAM assignments approximating 5:3
ratio within litters. Post-operative pups were returned to
their litters where they grew undisturbed under standard
conditions through weaning (PD 21), when they were pair-
housed. Pups remained in pairs though the initial injection
series and then were singly housed (PD 71) after cannula-
tion. All procedures accorded with NIH guide for Care and
Use of Laboratory Animals and the Indiana University
Institutional Animal Care and Use Committee.
PD 7 pups underwent NVHL/SHAM surgeries under
hypothermic anesthesia as originally described (Lipska et
al. 1993), with delivery of ibotenic acid (3.0 μg in 0.3 μl in
artificial CSF) vs. artificial CSF (0.3 μl) into the ventral
hippocampus bilaterally (AP −3.0, ML ±3.5, DV −5.0; from
bregma (millimeters)). Cannulation surgeries were conducted
on PD 71 under isofluorane anesthesia. Rats were randomized
to placement of a guide cannula (18 G/11 mm; Plastics One)
in the NAC SHELL (AP +2.1, ML +2.0, DV −4.5), NAC
CORE (AP +2.0, ML +2.6, DV −3.9), or CAPU (AP +1.9,
ML +3.1, DV −2.5; from bregma (millimeters) all 10° off
midline). Cannula was affixed to the skull with three screws
and a microdialysis tubing tether (Instech) with cranioplastic
cement. Unilateral (right) rather than dual cannulations were
used to minimize non-specific injury of neural systems that
might support the experimental phenotypes. Five days after
cannulations (PD 76), rats underwent brief isofluorane
anesthesia for placement of loop style probes (Kohl et al.
1998; 216 μm e.d.), with dialysis loops (Spectrum Labora-
tories, Rancho Dominguez, CA, USA) parallel with the AP
plane, and inserted to extend (4 mm at the tip) below the
guide cannula and cemented in place. The active membrane
dialysis length of the probe loop was 1.5 mm (i.e., 3.0 mm
total length) for all target regions.
Behavioral sensitization and microdialysis
Upon reaching adulthood (PD 60), rats were randomized to
5 days of once daily cocaine (15 mg/kg (NIDA) in 1 ml/kg
saline i.p.) or saline injections (1 ml/kg i.p.) in home cages
(Fig. 1). Two weeks later (PD 78), all rats underwent a
single cocaine injection (15 mg/kg) within a 210-min
locomotor arena session (under low red light) during
microdialysis collection. Arenas (43 43 31 cm) with
16×16 infrared beam detectors (Med Associates) were
equipped with microdialysis tubing swivel arms mounted
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above the field with dual channel swivels (Instech). Micro-
dialysis was conducted as previously described (Engleman
et al. 2003). Dialysis tubing coursed from infusion pump-
mounted syringes (Harvard Apparatus) through swivels to
dialysis probes protected by a spring sheath (Instech).
Outlet tubing coursed back through the swivel, terminating
at the elbow of the swivel arm where dialysate was
collected in microfuge tubes. Sessions began with hookup of
probe tubing and securing of tethers to the dialysis sheath.
Probes were perfused at 1.5 μl/min with aCSF containing (in
millimolars) 140 NaCl, 3 KCl, 2.5 CaCl2, 1.0 MgCl2,
2.0 Na2PO4, and 0.2 ascorbate adjusted to pH 7.4 with
0.1 N NaOH. For the first 90 min of the 210-min session,
rats habituated to the setup, followed by a 120-min recording
phase measuring distance ambulated in 10-min bins. Cocaine
injections were delivered at the 30-min point of the 120-min
recording phase. Sixteen microdialysis samples (15 μl) were
collected in 10 min intervals. Based on empirically verified
flow rates and length of outlet tubing, these collections
corresponded to four washout samples (during habituation),
three baseline samples (pre-injection locomotion), and nine
post-injection samples (post-injection locomotion).
HPLC detection of DA content
Samples were collected in microfuge tubes containing
5.0 μl of 0.1 N perchloric acid, immediately frozen on
dry ice then stored at −80° until analysis. HPLC/EC
analysis of DA was performed as described elsewhere
(Franklin et al. 2009). The system comprised an ampero-
metric microbore/Unijet cell with a 6-mm glassy carbon
electrode (BAS, Lafayette, IN, USA) coupled with a
Princeton Applied Research/EG&G electrochemical detec-
tor (Princeton Applied Research, Princeton, NJ, USA).
Samples with volumes of ~20 μl (including preservative)
were loaded into a 10-μl loop (sample loops were overfilled
with twice their volume as recommended to optimize
precision of sample analysis) and injected onto an analytical
column (BDS Hypersil C18, 3 μm, 1×100 mm; Keystone
Scientific, Bellefonte, PA, USA) with a mobile phase of
sodium acetate 6.32 g/l, EDTA 0.15 g/l, sodium octyl-sulfate
0.75 g/l, and 6% acetonitrile at pH 4.0. A single 6-mm glassy
carbon electrode was used at a potential of +500 mV, and DA
was detected at a sensitivity of 2.0 nA/V to optimize detection
of both baseline DA and several fold changes. This setup had
a minimum level of detection of approximately 0.1 nM
(1.0 fmol/10 μl). Output from HPLC detector was computer
compiled (ChromPerfect, Justice Innovations, Inc., Palo Alto,
CA, USA), and DA levels were determined by comparison
with a standard curve of known quantities of DA in similar
un-frozen preservative/aCSF solutions.
Lesion and cannulation verification
Rats were sacrificed immediately after microdialysis, after
which probes were injected with methylene blue, followed
by whole brain removal and rapid freezing in isopentane.
Cryostat-cut coronal brain sections (40 μm) were mapped
for probe placements (blue tracks) rostrally and for lesion
verification caudally. Sections cut through the hippocampus
were dehydrated, fixed, and thionin-stained. Lesion verifi-
cation, mapping of probe placement, and examination of
the fidelity of HPLC/DA detection were all conducted
independently and blind from behavioral results. All of
these conditions were assessed as sources of attrition.
Exclusions were called on lesioned animals with only
unilateral ventral hippocampal dysmorphology or significant
extra-hippocampal damage, extra-striatal probe placement or
related intracranial hemorrhage, dialysis probe blockage/
bursting, operational failure of HPLC, or contaminants
obscuring DA signal. A total of 211 rats were carried though
at least cannulation in 27 cohorts of eight over a 3-year period
toward a goal of reaching seven to nine non-excluded rats per
group (indexed by lesion status, drug history, and cannulation
Fig. 1 Experimental timeline
according to animal age (post-
natal day, PD)
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site). Cohorts were balanced by lesion status and drug history,
while two of three cannulation regions were rotated in across
cohorts. Dialysate from each cohort was HPLC analyzed in
the same batch, 2–4 weeks after microdialysis. At study
completion, 92 of 211 (44%) rats survived the sources of
attrition allowing subsequent analysis of sub-group Ns as
indexed in Table 1. Success rates of lesions or the behavioral
microdialysis/HPLC analysis were 74% and 59%, respec-
tively. Lesion and cannulation mappings of included animals
are shown in Fig. 2.
Data analysis
ANOVA examined independent factors of lesion status,
drug history, and cannulation region in a repeated measures
design with bins the within-subjects time factor. This 2
2 3 bins design was applied in separate examinations
of pre-injection and post-injection activities for behavioral
and DA data. Secondary ANOVAs of lower order and/or
post hoc Tukey tests characterized specific sub-group
differences where appropriate. Dependent behavioral meas-
ures were assessed per rat as pre-injection distance/bin and
post-injection distance/bin. Dependent DA measures were
DA concentration/bin (three pre-injection bins) and %DA
efflux (% increase over mean pre-injection DA concentra-
tion, at each of the nine post-injection bins). To more
directly explore relationships between post-injection behavior
and DA efflux, we focused on three additional summary
dependent variables: (a) mean post-injection locomotion
(calculated per rat as its average post-injection activity across
nine bins), (b) individual mean post-injection %DA efflux/bin
over the nine bins, and (c) peak %DA efflux (determined per
rat as its maximum amplitude %DA efflux post-injection).
Selecting the two treatment groups that showed the most
mutually extreme behavioral differences, we performed
simple two-way ANOVAs (group × region), on each of these
dependent variables. Finally, while including all 92 rats in the
study regardless of lesion status/drug history, we examined
Pearson correlations between the behavioral measures and
each of the %DA efflux measures. All data are presented as
means ± SEM; significance was recognized at p<0.05.
Results
Behavior
NVHLs showed increased locomotion in the 30-min pre-
injection phase (lesion: F(1, 80)=5.5, p<0.05), whereas
cocaine history, cannulation region, and bins had no effects
(Fig. 3, left). There were no interactions between any of
these main effects. In contrast, over the 90-min post-
injection phase, locomotor activity was significantly in-
creased by both NVHLs (F(1, 80)=11.3, p<0.01) and
cocaine history (F(1, 80)=4.7, p<0.05). There was also a
significant effect of bins (F(8, 640)=81.9, p<0.001) and a
bins × drug history interaction (F(8, 640)=2.2, p<0.05)
Fig. 2 Mapping of lesions and cannulation tracks of animals included
in the study. Upper left sections show the largest (black) and smallest
(white inset) lesion extents of NVHL animals used in the study. Upper
right micrographs show typically sized NVHL damage vs. SHAM.
Lower sections show cannulation placement for all rats included in the
study (N=92) by cannulation region. Coordinates are relative to
bregma (Swanson 2004)
Table 1 Study group sizes
Lesion/drug history Cannulation site
SHELL CORE CAPU
SHAM-SAL 7 9 8 24
NVHL-SAL 7 7 7 21
SHAM-COC 8 7 9 24
NVHL-COC 9 7 7 23
11 31 30 31 Total N=92
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indicative of behavioral sensitization (Fig. 4). Cannulation
site had no effect on post-injection locomotion, and there
were no interactions between any other factors.
Dopamine efflux
DA concentrations over the three pre-injection bins showed
a significant main effect of cannulation region (F(2, 80)=
6.5, p<0.01) but not lesion or drug history. There was also
a significant effect of bins (F(2, 160)=4.3, p<0.05)
associated with a small uptick (~10%) in DA concentration
in the last pre-injection bin, likely due to a slight retrograde
diffusion of increased DA from the adjacent post-injection
volume in the dialysis line. There were no interactions
between any main factors or bins. The non-significant
mean baseline DA concentrations of the four treatment
groups listed by cannulation region are shown in Table 2.
Post hoc examination of baseline DA concentrations
according to cannulation region, irrespective of lesion
status or drug history, revealed an anatomical gradient of
DA concentrations, where in comparison with the CAPU
region (N=31; 50.1±13.6 fmol/10 μl), DA levels were
marginally lower in the CORE (N=30; 22.3±3.8; p=
0.051) and significantly lower in the SHELL (N=31; 8.9±
1.5; p<0.01).
Fig. 4 Locomotor response to cocaine injections according to
presence or absence of cocaine history. Significant effects of drug
and bins × drug history interaction (*p<0.05) were identified. Data
depicted as means ± SEM, include all rats in the study regardless of
cannulation region or lesion status (cocaine history rats (N=47); saline
history rats (N=45))
Table 2 Baseline (pre-injection) DA concentrations (fmol/10 μl).
Data reflect group means of the means of the 3×10 min pre-injection
bin (± SEM)
Lesion/drug history Cannulation site
SHELL CORE CAPU
SHAM-SAL 8.1±2.9 16.6±5.7 87.9±49.5
NVHL-SAL 13.2±4.1 27.2±9.4 52.8±15.7
SHAM-COC 7.6±2.7 22.6±8.0 26.9±4.6
NVHL-COC 7.4±2.2 24.3±8.5 34.0±10.7
Fig. 3 Pre- and post-injection locomotion. Left Distance traveled per
10-min bin for the lesion/drug history groups. Lesions increase pre-
injection activity (−2, −1, 0 bins; *p<0.05) and increased further in
significance in the post-injection phase (bins 1–9; **p<0.01) where
drug history effects also emerged (*p<0.05). Right Total post-
injection locomotion. Data depicted as means ± SEM (error bars
below only for clarity) include all rats in the study regardless of
cannulation region (SHAM-SAL (N=24); NVHL-SAL (N=21);
SHAM-COC (N=24); NVHL-COC (N=23))
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In contrast to post-injection behavior, post-injection
%DA efflux did not show main effects of lesion or drug
history, though the lesion effect was marginal (F(1, 80)=
3.0, p=0.09) due to lower %DA efflux (mean across post-
injection bins) in NVHLs (N=44; 249±21%) compared to
SHAMs (N=48; 307±32%). Bins were also strongly
significant (F(8, 640)=31.5, p<0.001) consistent with the
effect of cocaine in causing a pronounced rise then fall of %
DA efflux. Similar to the pre-injection%DA data, cannulation
region again showed a significant effect (F(2, 80)=6.8, p<
0.01) and a region × bins interaction (F(15, 640)=3.8, p<
0.001; Fig. 5). However, the %DA efflux gradient expressed
opposite to the baseline DA concentrations; % DA efflux
(mean across post-injection bins) in the SHELL (N=31;
365±45) was marginally higher in comparison to CORE
(N=30; 272±30, p=0.098) and significantly higher than
CAPU (N=31; 201±12; p<0.01). Pearson correlation
including all rats in the study confirmed a significant
inverse relationship between mean baseline DA levels and
mean post-injection %DA efflux (R=−0.284, p<0.01). No
other interactions between main effects or bins were noted
in post-injection %DA with the exception of a complex
significant four-way interaction (lesion × drug history ×
region × bins: F(16, 640)=1.68, p<0.05). Post hoc
examinations of %DA efflux performed at each post-
injection bin that compared the 12 subgroups (indexed by
lesion status, drug history, cannulation region) revealed
that SHELL-cannulated SHAM-COC rats showed signifi-
cantly greater %DA efflux than five of the 11 other subgroups
(all four of the CAPU-cannulated groups and the CORE-
NVHL-SAL group), across the second, third, and fourth post-
injection bins (p<0.05), while none of the other 11
subgroups were mutually different at any post-injection bin
(Fig. 6). While suggestive of a neurochemical sensitization
isolated to SHAM-COC rats in the early portion of the %DA
curve, this finding was not robust to secondary repeated
measures ANOVAs performed on %DA efflux for each
region separately (lesion × drug history × bins). Neither
lesion nor drug history significantly modulated %DA as
main effects or interactions, in the SHELL, CORE, or
CAPU, although bins were again robustly significant in all
regions (SHELL (F(8, 216)=11.8, p<0.001); CORE (F(8,
208)=18.2, p<0.001); CAPU (F(8, 216)=26.1, p<0.001)).
Notably, significant behavioral effects of lesion or drug
history would still be detectible given the same ANOVA of
post-injection locomotion at each region separately: (SHELL
(bins: F(8, 216)=24.6, p<001; lesion: F(1, 27)=7.5, p<
0.01)), (CORE (bins: F(8,208)=25.6, p<0.001; drug history:
F(1, 26)=4.6, p<0.05; drug history × bins: F(8, 208)=2.1,
p<0.05)), (CAPU (bins: F(8, 216)=35.2, p<0.001; lesion
F(1, 27)=8.2, p<0.01)).
DA efflux as a predictor of behavior
SHAM-SAL (N=24) and NVHL-COC (N=23) groups
demonstrated the largest mutual differences in post-
injection locomotion (Fig. 3) and extreme low and high
ranges in behavior among all four treatment groups. Two-
way ANOVA (group × region) confirmed a robust
difference in mean post-injection locomotion between these
two groups (F(1, 41)=24.6, p<0.001; Fig. 7). However,
two-way ANOVAs applied to %DA efflux measures
revealed no effect of group on either mean post-injection
%DA efflux or post-injection individual peak %DA efflux.
Cannulation region had no significant main effect or
interactions with group in any of these analyses. Pearson
testing including all rats cannulated in the SHELL (N=31),
irrespective of lesion status or drug history, found no
correlation between mean post-injection locomotion and
mean post-injection %DA efflux, mean post-injection DA
concentrations, or post-injection individual peaks in %DA
efflux. The same correlations performed for CORE (N=30)
and CAPU (N=31) rats also found no significant relation-
ships between behavior and any of these DA measures.
Discussion
In measuring DA efflux across SHELL, CORE, and
CAPU compartments in real time with behavior after
cocaine injections, significant behavioral differences due
to NVHLs, with or without a behavioral sensitizing
cocaine history, were not underpinned by differences in
Fig. 5 %DA efflux across post-injection bins (1–9) according to
cannulation region. Significant main effects of region (**p<0.01) and
bins × region (***p<0.001) were identified. Data depicted as means ±
SEM include all rats in the study regardless of drug history or lesion
status (SHELL (N=31); CORE (N=30); CAPU (N=31))
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cocaine-induced %DA efflux. Pre-injection DA levels
were also not different between treatment groups even
though mild pre-injection behavioral NVHL effects were
observed. Although the no-net flux method would be
needed to precisely measure absolute baseline DA levels,
the absence of relative differences in baseline DA in this
study with large rat numbers, together with no lesion or
drug history effects on post-injection %DA efflux,
suggests that altered DA transmission is not the key
mechanism of increased acute or behaviorally sensitized
cocaine-induced locomotion in NVHLs.
Several aspects of our data suggest that our behavioral
microdialysis approach was adequate for supporting the
conclusions of this study. First, a significant behavioral
sensitization effect was demonstrated in cocaine history rats
(Figs. 3 and 4), and we observed a close temporal
correspondence and similarity of form of locomotor and
DA curves with respect to timing of cocaine injections
(Fig. 6). Second, irrespective of lesion status or drug
history, we identified a trans-striatal anatomical gradient
from SHELL to CORE, to CAPU, of both baseline DA
levels and %DA efflux and an inverse correlation between
the two variables along this gradient. Similar trans-striatal
gradients have been shown in numerous studies spanning
mice, rats, and monkeys (Becker et al. 2001; Bradberry et
al. 2000; Frank et al. 2008; Mattsson et al. 2007; Navailles
et al. 2004; Pontieri et al. 1995; Watanabe et al. 2005;
Zocchi et al. 2003), including identification of an inverse
correlation between baseline DA and %DA efflux
(Heidbreder et al. 1996). To our knowledge, this report
is the first to document this gradient across all three of
these regions in the same rodent study. Thus, our DA
detection was more than adequate for detecting differences
in baseline and %DA efflux by striatal region at levels
comparable to available data. Finally, not only were no
lesion/drug history group differences in %DA efflux found
Fig. 6 Locomotor response (up-
per) and %DA efflux curves
(lower) of all rats in the study by
cannulation region and lesion/
drug history status (SHELL, N=
31; CORE, N=30; CAPU, N=
31). Significant main effects or
their interactions are noted at
*p<0.05, **p<0.01,
***p<0.001 levels from the
four-way repeated measures
ANOVAs on post-injection be-
havior or %DA efflux conducted
separately. Error bars (± SEM)
are below only for visual clarity.
Behavioral Y-axis scales are the
same across regions for behavior
but are adjusted lower dorsally
for %DA efflux curves for
visual clarity
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overall when including the variance due to region sampled
but also there were no differences within regions or other
special comparisons. When observing non-significant
trends in the DA data, NVHLs showed overall marginal
(p=0.09) decreases in %DA efflux, while limited statistical
evidence for a neurochemical sensitization only emerged for
SHELL-cannulated SHAM-COC rats in the early phase of
the %DA efflux curve. When directly comparing NVHL-
COC to SHAM-SAL rats (the comparison that carried the
largest behavioral contrast), both mean post-injection %DA
efflux and maximum peak% DA efflux in NVHL rats were
similar to or trended lower than SHAMS. When including all
rats in the study, correlations between individual post-
injection behavior and post-injection %DA efflux or peak
%DA did not exist.
Cannulation of differential striatal regions did not impact
behavior as a main effect or interaction with lesion or
cocaine history. When including all rats regardless of
cannulation region, we observed behavioral sensitization
in SHAM and NVHL rats in statistical patterns consistent
with prior studies (Chambers and Taylor 2004; Berg and
Chambers 2008; Chambers et al. 2010). However, we did
see weakening of behavioral group differences when
assessing each cannulation region separately where N’s
were only 1/3 as large as the overall group, due to loss of
statistical power related to the behavioral microdialysis
procedure. Stress from the recent cannulation and probe
placements, tethering of animals, and repeated entry of
investigators to collect dialysate all likely diluted or
suppressed phenotypic behavioral differences. In compari-
son to a parallel study with six to nine rats per lesion/drug
history group that did not incorporate microdialysis
(Chambers et al. 2010), results here showed the same
statistical outcome but a more narrow range of behavioral
differences. Relative increases in the SHAM-SAL group
and relative decreases in the NVHL-COC group were
consistent with concurrent “raised floor” and “lowered
ceiling” effects on the range of locomotion.
Our results are in general agreement with all prior
published examinations of DA efflux in the NVHL model,
which in using voltammetry or microdialysis/HPLC detec-
tion of DA in the NAC, either at baseline or in response to
novelty, stress, or amphetamine, also found no change or
small decrements in DA efflux (Brake et al. 1999; Corda et
al. 2006; Lillrank et al. 1999; Wan et al. 1996). The
qualifying exception to this is the observation of Corda et
al. that while overall DA efflux in the NAC after acute
amphetamine was unchanged in NVHLs (and no baseline
lesion differences in NAC SHELL or CORE DA levels
were present), there was a relative decrease of %DA efflux
in the SHELL and increase in the CORE in NVHLs (Corda
et al. 2006). It is unclear why we did not replicate these
sub-region specific observations, although pharmacological
differences between cocaine and amphetamine doses used
may be a possibility (Cadoni et al. 2000). The present study
also differs from Corda et al. by examining acute drug
injections with and without prior drug history and across a
broader anatomy of three striatal regions. Thus, in a more
comprehensive examination of anatomy and experimental
Fig. 7 Post-injection behavior and DA measures of the two treatment
groups (SHAM-SAL (N=24) vs. NVHL-COC (N=23)) that repre-
sented the widest extremes of post-injection behavior. Mean post-
injection locomotion (top panel) of the NVHL-COC group was
robustly greater than the SHAM-SAL group (***p<0.001) but mean
post-injection %DA efflux and mean peak %DA efflux (lower panels)
were not different between the groups. Data are depicted as means ±
SEM
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conditions, the present findings add weight to a general
conclusion that NVHLs do not alter psychostimulant-
induced sub-cortical DA efflux, and NVHL increases in
DA-mediated behavior are not primarily caused by
increased DA efflux.
The present results conflict with expectations that might
arise from literal interpretations of DA hypotheses of
addictions or schizophrenia, e.g., addicted and/or schizo-
phrenic states = increased sub-cortical DA. However, our
findings are consistent with several lines of evidence
depicting a more nuanced role for DA transmission in
these disorders in which DA acts primarily to mediate or
express pathological change involving other neural sys-
tems, rather than serving itself as a direct biomarker of
pathological change. While changes in mesolimbic DA
efflux with behavioral sensitization have been documented,
the literature is mixed on whether neurochemical sensitiza-
tion of DA is required for or is the primary mechanism
driving sensitized behavior (Chefer and Shippenberg 2002).
If and how DA efflux changes with repeated drug
exposures appears more closely related to the dosing
regimen, time between induction series and challenge, and
NAC region being examined, and not whether behavioral
sensitization occurs (Heidbreder et al. 1996; Cadoni et al.
2000). In a prior study using a regimen similar to our own
(5 days cocaine, 20 mg/kg/day; cocaine challenge 12 days
later) behaviorally sensitized Sprague–Dawley showed less
% DA efflux than those with only saline histories
(Heidbreder et al. 1996). Meanwhile, an emerging body of
evidence suggests that long-lasting behavioral and motiva-
tional changes due to addictive drug exposure are instan-
tiated by a host of neuroadaptations post-synaptic to
mesolimbic DA transmission (Kauer and Malenka 2007).
Drug-induced DA efflux facilitates abnormal dendritic and
synaptic changes involving glutamatergic synapses within
neostriatal networks that mediate habit formation—operat-
ing as a mechanism that does not require changes in drug-
induced DA efflux over time (Kalivas and O’Brien 2008;
Redish 2004; Vanderschuren and Kalivas 2000). Consistent
with this view of DA, NVHL investigations have identified
lesion-induced changes in frontal cortical–striatal circuits
that are projection fields of both ventral hippocampus and
mesolimbic DA fibers but little evidence for changes in DA
transmission (Tseng et al. 2009). When NVHL vs. SHAM
rats are given similar levels of experimentally induced DA
stimulation, they show differential activation of post-
synaptic glutamatergic and GABAergic neurons within
cortical–striatal networks (Goto and O’Donnell 2004;
O’Donnell et al. 2002; Tseng et al. 2007, 2008). Thus,
dysfunctional cortical–striatal responsiveness to DA,
brought on by NVHLs or addictive drug history, may drive
their corresponding behavioral phenotypes, without requir-
ing substantial pathological changes in levels of provoked
DA efflux. With respect to schizophrenia, this view agrees
with a post-synaptic interpretation of the DA hypotheses
that is supported by a historical majority of human
investigations that have failed to document or substantially
replicate direct evidence for increased sub-cortical DA
transmission in schizophrenia, untangled from effects of
neuroleptics (Laruelle and Abi-Dargham 1999). However,
recent neuroimaging, using indirect measures of DA efflux
(radio-tracers of DA precursors or DA receptor radioligand
binding displacement after amphetamine), has suggested
increased striatal DA outflow that may vary by symptom
severity or medications (Breier et al. 1997; Laruelle and
Abi-Dargham 1999; McGowan et al. 2004). Further studies
are needed to understand the extent to which these and the
present findings differ based on subject species/illness
model, DA detection methodology, or potential confounds
of concurrent or recent substance exposures not generally
accounted for in human studies.
In terms of understanding mechanisms underlying dual
diagnosis, we have shown in a parallel study examining
cortical and striatal neuronal activation as measured by
expression of c-Fos densities that NVHLs and a behaviorally
sensitizing cocaine history produce compounding effects
across cortical–striatal compartments (Chambers et al. 2010).
Cocaine compared to saline history produces a gradient of
increasing striatal activation from SHELL to CORE to
CAPU, while NVHLs alone produce a paucity of medial
prefrontal cortical activation. When combining these con-
ditions, the striatal effects of cocaine history are quantitatively
amplified in proportion to NVHL-based medial prefrontal
cortical hypo-activation, corresponding to CAPU c-Fos
density levels that directly correlate with locomotor output.
By not mirroring these trends across ventral and dorsal striatal
compartments in terms of DA efflux and showing no
relationship between behavioral output and DA efflux in
any striatal region, the present results provide further evidence
that altered cortical–striatal network functional and neuro-
adaptative responses to DA stimulation and not DA efflux per
se are the more crucial mechanisms mediating an integrated
neurobiology of addictions vulnerability in mental illness.
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